Case of the week 33/2019


Use of CytoSorb in hyperbilirubinemia due to severe post resuscitation shock
Dr. med. Hendrik Haake, Dr. med. Katharina Grün-Himmelmann & Prof. Jürgen vom Dahl
Department of Cardiology and Intensive Care Medicine, St. Franziskus-Hospital Mönchengladbach, Germany

This case reports on a 63-year-old male patient (known pre-existing conditions: ischemic cardiomyopathy), who was hospitalized with ventricular tachycardia and hypotension.


The Therapy

An extracorporeal blood purification therapy to reduce excessive inflammation mediators

The Fields of Application

Treat septic shock & severe sepsis on ICU, prevent SIRS in cardiac surgery patients

The Studies

Current multi- and monocentric study projects in Europe and US, an international registry, case series

The Adsorber

A cutting edge bead technology turns CytoSorb into the only specifically approved extracorporeal cytokine adsorber

CytoSorb registry

Become part of the International CytoSorb registry!

For the first time treatment data, courses of treatment and results of a new treatment are systematically recorded according to highest scientific standards.